![]() |
Volumn 71, Issue 1-2, 2002, Pages 171-181
|
Chronic exposure to the opioid growth factor, [Met5]-enkephalin, during pregnancy: Maternal and preweaning effects
|
Author keywords
Development; Enkephalin; Fetus; Growth factors; Neonate; Opioid growth factor; Opioids; Prenatal; Transplacental
|
Indexed keywords
METENKEPHALIN;
NALOXONE;
OPIATE PEPTIDE;
ANIMAL BEHAVIOR;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
BODY WEIGHT;
CHILDBIRTH;
CONTROLLED STUDY;
CROWN RUMP LENGTH;
CYANOSIS;
DRUG DEPENDENCE;
DRUG EFFECT;
DRUG WITHDRAWAL;
FEMALE;
FETUS;
FLUID INTAKE;
FOOD INTAKE;
HISTOPATHOLOGY;
LETHARGY;
LITTER SIZE;
LONG TERM EXPOSURE;
MALE;
MATERNAL BEHAVIOR;
NEWBORN;
NOCICEPTION;
NONHUMAN;
ORGAN WEIGHT;
PREGNANCY;
PRIORITY JOURNAL;
RAT;
STILLBIRTH;
WEANING;
WEIGHT GAIN;
ANIMALS;
ANIMALS, NEWBORN;
ENKEPHALIN, METHIONINE;
FEMALE;
FETAL DEATH;
LABOR, OBSTETRIC;
LITTER SIZE;
LUNG;
MALE;
MATERNAL EXPOSURE;
OPIOID PEPTIDES;
ORGAN SIZE;
PREGNANCY;
PREGNANCY, ANIMAL;
PRENATAL EXPOSURE DELAYED EFFECTS;
RATS;
RATS, SPRAGUE-DAWLEY;
WEANING;
|
EID: 0037006064
PISSN: 00913057
EISSN: None
Source Type: Journal
DOI: 10.1016/S0091-3057(01)00649-9 Document Type: Article |
Times cited : (15)
|
References (58)
|